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Purpose. To describe the characteristics of idiopathic macular holes (MH) on optical coherence tomography (OCT) and correlate
OCT with clinical assessment. Design. Cross-sectional chart review and OCT assessment. Participants. Sixty-seven eyes with a
clinically diagnosed idiopathic MH with available OCT data. Methods. A retrospective chart review and OCT assessment. Results.
BasedonOCTgrading,40eyeshadafull-thicknessmacularhole(FTMH)and21eyeshadalamellarmacularhole(LMH).Clinical
exam and OCT assessment agreed in 53 (87%) eyes when assessing the extent of MH. Six eyes (14.6%) in the FTMH group, and
3 eyes in the LMH group (14.3%) had persistent vitreomacular traction. Thirty-seven eyes (92.5%) in the FTMH group and 11
eyes (52.4%) in the LMH group had associated intraretinal cysts. Two eyes (5.0%) in the FTMH group and zero eyes in the LMH
grouphad subretinalﬂuid.Intraretinal cysts were foundto bemore frequently associated with FTMHthan with LMH(P<0.001).
Conclusion. This paper described OCT ﬁndings in a group of patients with clinically diagnosed MH. A high level of correlation
between clinical assessment and OCT ﬁndings of LMH and FTMH was observed, and intraretinal cysts were often present in
FTMH.
1.Introduction
For decades, macular holes (MH) have been classiﬁed by
fundus biomicroscopy in four stages, as ﬁrst described by
Donald Gass in 1988 [1, 2]. The Gass classiﬁcation is based
on the fovea appearance, the estimated size of the hole, and
whether or not the posterior vitreous is separated (Table 1).
Conﬁrmation of full-thickness macular holes (FTMH) can
be performed with further clinical investigations such as
Amsler grid assessment, the Watzke-Allen sign, or the laser
aiming beam test [3].
Optical coherence tomography (OCT) has enhanced
our understanding of MH by providing an objective and
reproducible way of visualizing the macula. It conﬁrmed the
pathogenesisofidiopathicMHbyintroducingtheconceptof
stage 0 macular hole, or vitreomacular traction (VMT) [4].
OCT provides conﬁrmation of clinical ﬁndings, further
anatomic characterization, means of educating patients, and
improved staging of MH. In a study of 61 eyes with all stages
of MH, OCT oﬀered additional or diﬀerent information in
92% of stage 1MH [5]. Clinical assessment of late-staged
MH is enhanced with OCT by enabling measurement of the
diameter of the MH and visualizing the posterior hyaloid.
The purpose of this study was to describe OCT ﬁndings
of idiopathic MH in a series of consecutive patients seen at a
single tertiary care practice.
2. Methods
A retrospective chart review was performed at the Henkind
EyeInstituteattheMonteﬁoreMedicalCenterinBronx,New
York. Institutional Review Board approval was obtained for
thisstudy.Allresearchwascarriedoutinaccordancewiththe
Health Insurance Portability and Accountability Act of 1996.
An initial search for the diagnosis of “macular hole”
(International Classiﬁcation of Diseases Ninth Revision
362.54) was done among 15,600 patient visits in the clinic
database over a three-year time period. Charts were reviewed
to conﬁrm the clinical diagnosis of MH, and only idiopathic2 Journal of Ophthalmology
Table 1: Modiﬁed Gass classiﬁcation system of macular holes.
Stage Description
Stage 1a Yellow spot with loss of foveal depression, no vitreous
separation
Stage 1b Yellow ring with loss of foveal depression, no vitreous
separation
Stage 2 Small full-thickness macular hole < 400microns
Stage 3 Full-thickness macular hole > 400microns, no vitreous
separation
Stage 4 Full-thickness macular hole > 400microns, complete
vitreous separation
MH were included. Macular holes associated with trauma,
retinal detachment, diabetic retinopathy, or myopia were
excluded. Macular pseudoholes (MPH) associated with
an epiretinal membrane by clinical diagnosis were also
excluded. Patients with the initial clinical diagnosis of MH
but no OCT were also excluded. Charts were reviewed for
demographical (age, sex) and clinical information (visual
acuity, clinical staging).
OCT was taken with time-domain OCT (Stratus OCT,
Carl Zeiss Meditec, Inc., Dublin, CA, USA) using 6-line
raster protocol or spectral-domain OCT (Cirrus OCT, Carl
Zeiss Meditec, Inc., Dublin, CA, USA) using 5-line raster
protocol. Assessment of OCT was based on both chart data
and, when available, realtime imaging on the scanner. OCT
review was done by two observers. OCT was evaluated for
the extent of MH formation, for example, lamellar macular
hole (LMH) versus FTMH. Additional OCT ﬁndings such as
the presence of VMT seen as foveal vitreomacular adhesion,
intraretinal cysts, and subretinal ﬂuid (SRF) were evaluated.
The relationship between OCT ﬁndings and the extent of
MH and the agreement between clinical diagnosis and OCT
diagnosis (LMH versus FTMH) were assessed using Chi-
square tests.
3. Results
An initial search by ICD-9 code revealed 133 patients with
the diagnosis of MH. A total of 112 charts were available for
review. Eighty eyes met inclusion criteria for idiopathic MH
by clinical documentation. Among these eyes, 67 eyes had
available OCT data at presentation.
The mean age of patients was 71 years (range 35–97
years.) Forty-nine (69%) patients were female, accounting
forafemale-to-maleratioof2.2:1.Bestcorrectedvisualacu-
ity (BCVA) at presentation ranged from 20/25 to counting
ﬁngers (CF.) Forty-eight (60%) eyes had BCVA ≤ 20/200.
Twenty eyes (25%) had BCVA ≥ 20/40. Twenty eyes were
clinically diagnosed as LMH and 43 eyes as FTMH. The
median BCVA was 20/70 in LMH group and 20/200 in
FTMH group.
3.1.OCTFindings. Among67eyeswithOCTdata,32(48%)
had TD-OCT, and 37 (55%) had SD-OCT. Four eyes were
found to have epiretinal membrane with MPH and 2 eyes
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Figure 1: Optical coherence tomography of full-thickness macular
holes (a) with separation of the posterior vitreous from the fovea
and (b) with vitreomacular traction. Note the diﬀerence in foveal
contour, as well as the presence of intraretinal cysts.
with resolved MH on OCT were excluded from the ﬁnal
analysis. Based on OCT grading, 40 eyes (66%) had FTMH
and 21 eyes (35%) had LMH. Six (15%) of 40 eyes with
FTMH by OCT evaluation had VMT versus 3/21 (14%) eyes
with an LMH. Thirty-seven (93%) of 40 eyes with an FTMH
by OCT evaluation had associated intraretinal cysts versus
11/21 (52%) eyes with a LMH. Two of 40 (5%) eyes with
an FTMH by OCT evaluation had SRF versus zero eyes with
an LMH. Intraretinal cysts were found to be more frequently
associated with FTMH than in LMH (P<0.001; Table 2).
3.2. Clinical Exam and OCT Agreement. Overall, clinical
exam and OCT data agreed in 53 (87%) eyes when assessing
the extent of IMH (LMH versus FTMH.) The rate of
agreement was higher in the OCT-conﬁrmed FTMH group
(93%) than in the OCT-conﬁrmed LMH group (76%)
(P<0.1; Table 2).
4. Discussion
This paper was a descriptive OCT study of idiopathic MH
captured at a large tertiary care center. Besides distinguishing
LMH and FTMH, OCT data provided additional informa-
tion such as the presence of VMT, intraretinal cysts, and
SRF. VMT occurred at about the same rate (14-15%) in
both LMH and FTMH. An example of an FTMH with
and without VMT is shown in Figure 1. Intraretinal cysts
were found to be signiﬁcantly more common in FTMH
than in LMH. Figures 1–3 demonstrate intraretinal cysts; the
presence of cysts on OCT in all stages of MH formation has
been previously reported [6, 7]. SRF was uncommon in bothJournal of Ophthalmology 3
Table 2: Optical coherence tomography (OCT) summary (MH = macular hole; VMT = vitreomacular traction; IRC = intraretinal cysts;
SRF = subretinal ﬂuid).
Additional OCT ﬁndings
Agreement with clinical exam (%)
OCT diagnosis VMT (%) IRC (%) SRF (%)
Total MH (n = 61) 9 (15) 48 (79) 2 (3) 53 (87)
Lamellar MH (n = 21) 3 (14) 11 (52) 0 (0) 16 (76)
Full-thickness MH (n = 40) 6 (15) 37 (93) 2 (5) 37 (93)
P value >0.1 <.001 >0.1 <0.1
(a)
(b)
Figure 2: Optical coherence tomography of (a) a lamellar macular
hole and (b) an epiretinal membrane with macular pseudohole.
Note the diﬀerence in foveal contour, as well as intraretinal cysts.
N T
Figure 3:Opticalcoherencetomographyofalamellarmacularhole
with a smooth foveal contour. Notice intraretinal cysts.
LMH and FTMH among our patients. Fellow eyes should be
imaged as well to look for subclinical VMT and intraretinal
cysts, as these factors indicate increased risk of developing
MH [6].
LMH were classiﬁed as a partial-thickness MH which
showedanirregularityofthecontouratthefovealcenter,and
MPH as partial-thickness retinal defects associated with an
epiretinal membrane and smooth conﬁguration at the foveal
center (Figure 2.) These two entities are generally considered
diﬀerent from each other [8, 9]. However, the distinction
between MPH and LMH was not always clear. For example,
oneeyehadasmoothcontouratthefovealcenterwithoutthe
presenceofanepiretinalmembrane(Figure 3).Furthermore,
Michalewski et al. have reported a case of MPH that evolved
into a lamellar IMH [10].
In the present study overall agreement between clinical
examination and OCT was 87% and higher in the FTMH
group than in the LMH group. However, clinicians were not
blinded to the OCT results at time of clinical exam, thus
the true rate of agreement may be lower, highlighting the
utility of OCT in characterizing and staging MH. It would be
interesting to assess the sensitivity and speciﬁcity of clinical
examination for the diagnosis of MH, using OCT as the
gold standard. Given its low incidence, however, this would
require imaging a very large number of eyes.
OCT has greatly advanced innovations in the treatment
for MH by oﬀering an objective means of assessing MH
closure. For example, the necessity of internal limiting
membrane (ILM) peeling, adjunctive ILM staining, and
postoperative positioning are controversial concepts, which
have recently been evaluated by OCT [11–13]. Clinical trials
withmicroplasmin forthenonsurgical closureofFTMHalso
used OCT as a primary outcome [14].
A limitation of the present study is the retrospective
data collection and use of two diﬀerent OCT machines.
Therefore, our OCT analysis was limited to subjective eval-
uation without quantitative comparisons. Although OCT
provides anatomical information about the fovea, other
imaging modalities, such as autoﬂuorescence and ﬂuorescein
angiography, can provide functional information of the
underlying retinal pigment epithelial cells [15, 16]. These
additional tests can be considered for prospective studies on
MH.
In summary this study described OCT ﬁndings in a
group of patients with clinically diagnosed MH. A high
level of correlation between clinical assessment and OCT
ﬁndings of LMH and FTMH was observed; intraretinal cysts
were often present in FTMH. Understanding of the etiology
and management of MH has evolved with the use of OCT
technology.
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